These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bortezomib Does Not Prevent the Occurrence of Kaposi's Sarcoma in Patients with Haematological Malignancies: Two Case Reports. Chavarot N; Lebbe C; Thervet E; Bouscary D; Karras A Acta Derm Venereol; 2017 Oct; 97(9):1138-1139. PubMed ID: 28597021 [TBL] [Abstract][Full Text] [Related]
3. Lenalidomide in treating AIDS-related Kaposi's sarcoma. Martinez V; Tateo M; Castilla MA; Melica G; Kirstetter M; Boué F AIDS; 2011 Mar; 25(6):878-80. PubMed ID: 21412067 [No Abstract] [Full Text] [Related]
4. Thalidomide in Kaposi sarcoma: promising or disappointing? Laffitte E Dermatology; 2007; 215(3):171-2. PubMed ID: 17823510 [No Abstract] [Full Text] [Related]
15. A juvenile case of classic Kaposi's sarcoma. Erdem T; Atasoy M; Akdeniz N; Parlak M; Ozdemir S Acta Derm Venereol; 1999 Nov; 79(6):492-3. PubMed ID: 10598779 [No Abstract] [Full Text] [Related]
17. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not". Volkow P; Zinser JW; Correa-Rotter R BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117 [TBL] [Abstract][Full Text] [Related]
18. Jekyll and Hyde: a new license for thalidomide? Saphir A J Natl Cancer Inst; 1997 Oct; 89(20):1480-1. PubMed ID: 9337341 [No Abstract] [Full Text] [Related]
19. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. Dezube BJ Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241 [TBL] [Abstract][Full Text] [Related]
20. Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid. Bonhomme L; Fredj G; Averous S; Szekely AM; Ecstein E; Trumbic B; Meyer P; Lang JM; Misset JL; Jasmin C Ann Oncol; 1991 Mar; 2(3):234-5. PubMed ID: 2043496 [No Abstract] [Full Text] [Related] [Next] [New Search]